Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

Because of the conflicting data concerning the SARS-CoV inhibitory efficacy of ribavirin, an inosine monophosphate (IMP) dehydrogenase inhibitor, studies were done to evaluate the efficacy of ribavirin and other IMP dehydrogenase inhibitors (5-ethynyl-1-β-d-ribofuranosylimidazole-4-carboxamide (EICA...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnard, Dale L., Day, Craig W., Bailey, Kevin, Heiner, Matthew, Montgomery, Robert, Lauridsen, Larry, Winslow, Scott, Hoopes, Justin, Li, Joseph K.-K., Lee, Jongdae, Carson, Dennis A., Cottam, Howard B., Sidwell, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114261/
https://www.ncbi.nlm.nih.gov/pubmed/16621037
http://dx.doi.org/10.1016/j.antiviral.2006.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114261/
https://www.ncbi.nlm.nih.gov/pubmed/16621037
http://dx.doi.org/10.1016/j.antiviral.2006.03.001

Ejemplares similares